Half Year 2024 Dassault Systemes SE Earnings Call Transcript
Key Points
- Dassault Systemes SE (DASTF) reported a 4% increase in total revenue and an 8% rise in earnings per share for Q2 2024.
- The company has a robust pipeline for the second half of the year, with expectations to close the majority of delayed deals.
- Strong demand for the 3DEXPERIENCE solution in the manufacturing industry, with a 23% growth in the first semester.
- Significant competitive wins, including Mahindra & Mahindra, Bristol Myers Squibb, and Marmon, showcasing the company's ability to displace competitors.
- Continued investment in AI-driven use cases and new product launches, such as MEDIDATA Clinical Data Studio, which are expected to drive future growth.
- Delays in customer decisions impacted Q2 results, causing a shortfall in revenue.
- The aerospace and defense sector faced challenges due to manufacturing ramp-up delays and supply bottlenecks, affecting investment plans.
- Life sciences growth was negative for H1, with MEDIDATA growth at -3%, reflecting a challenging market environment.
- Operating margin for Q2 was below the low-end of guidance at 29.9%, impacted by fewer large deals and cautious customer signings.
- Subscription revenue growth was lower than expected at 8%, primarily due to delayed customer signings impacting large subscription contracts.
Thank you for joining our second-quarter 2024 earnings conference call with Pascal Daloz, Chief Executive Officer; and Rouven Bergmann, Chief Financial Officer.
Dassault Systemes results are prepared in accordance with IFRS. The financial figures discussed on this conference call are on a non-IFRS basis with revenue growth rates on a constant currency basis, unless otherwise noted.
Some of the comments on this call contain forward-looking statements that could differ materially from actual results. Please refer to today's press release and the Risk Factors section of our 2023 Universal Registration Document. All earnings materials are available on our website, and these prepared remarks will be available shortly after this call.
I would like now to hand over to Pascal Daloz.
Thank you, Beatrix. Good morning, good afternoon to everyone joining us on the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
